Glucagon-like peptide-1 receptor agonists (GLP-1RAs), which have valid glucose-lowering efficacies as well as notable weight-loss effects, are beneficial for diabetes therapy, especially for patients with overweight/obesity. Here, GLP1R is linked to diabetes mellitus.